Changes in the endometrium in treatment of breast carcinoma with tamoxifen
Reslová, T.; Tosner, J.; Vávrová, I.; Resl, M.
Ceska Gynekologie 62(5): 277-279
1997
ISSN/ISBN: 1210-7832 PMID: 9600168 Document Number: 476305
A group of twenty postmenopausal breast cancer patients treated with tamoxifen was used for examination of the endometrial morphology, role of transvaginal sonography, and consequences of insufficient collaboration between gynaecologist and oncologist. One case of endometrial carcinoma, one case of abnormal hyperplasia, and ten endometrial polyps in asymptomatic patients support the need for routine transvaginal sonography as a screening method. Any uterine bleeding should be evaluated by hysteroscopy.
Document emailed within 1 workday
Related Documents
Lindahl, B.; Andolf, E.; Ingvar, C.; Ranstam, J.; Willén, R. 2008: Adjuvant tamoxifen in breast cancer patients affects the endometrium by time, an effect remaining years after end of treatment and results in an increased frequency of endometrial carcinoma Anticancer Research 28(2b): 1259-1262Gelmann, E.P. 1997: Tamoxifen for the treatment of malignancies other than breast and endometrial carcinoma Seminars in Oncology 24(1 Suppl 1: S1
Ivanova, V.; Karaivanov, M.; Marinov, E.; Gorchev, G.; Velkova, A.; Khristova, P. 2003: Pathology of the endometrium in breast cancer patients treated with tamoxifen (nolvadex) Akusherstvo i Ginekologiia 42(5): 3-8
De Jong-Busnac, M. 1989: Ophthalmologic complications of low-dosage tamoxifen in the treatment of breast carcinoma Nederlands Tijdschrift Voor Geneeskunde 133(10): 514-516
Gonçalves, M.A.; Gonçalves, W.J.; Matias, M.M.; Nazario, A.C.; de Lima, G.R.; Baracat, E.C. 1999: Hysteroscopic evaluation of the endometrium of post-menopausal patients with breast cancer before and after tamoxifen use International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 66(3): 273-279
Baldini, B.; Taddei, G.L.; Tiso, E.; Visioli, C.B.; Campos, K.J.; Napolitano, A.C.; Tantini, C. 1996: Hysteroscopic evaluation of the endometrium in 63 postmenopausal patients treated with tamoxifen for breast cancer Minerva Ginecologica 48(6): 259-262
Bezircioglu, I.; Baloglu, A.; Tarhan, M.O.; Oziz, E.; Yigit, S. 2012: Evaluation of endometrium by transvaginal ultrasonography and Doppler in tamoxifen-treated women with breast cancer European Journal of Gynaecological Oncology 33(3): 295-299
Howell, A.; Harland, R.N.; Barnes, D.M.; Baildam, A.D.; Wilkinson, M.J.; Hayward, E.; Swindell, R.; Sellwood, R.A. 1987: Endocrine therapy for advanced carcinoma of the breast: relationship between the effect of tamoxifen upon concentrations of progesterone receptor and subsequent response to treatment Cancer Research 47(1): 300-304
Abdus-Salam, A.A.; Moharson-Bello, I.A.; Eriba, L.O.; Abdus-Salam, R.A. 2013: Metachronus endometrial carcinoma in a seventy five year old woman with carcinoma of the left breast treated with tamoxifen African Journal of Medicine and Medical Sciences 42(3): 271-275
Chiesa, M.Dalla.; Passalacqua, R.; Michiara, M.; Franciosi, V.; Di Costanzo, F.; Bisagni, G.; Camisa, R.; Buti, S.; Tomasello, G.; Cocconi, G. 2007: Tamoxifen vs Tamoxifen plus 13-cis-retinoic acid vs Tamoxifen plus Interferon alpha-2a as first-line endocrine treatments in advanced breast cancer: updated results of a phase II, prospective, randomised multicentre trial Acta Bio-Medica: Atenei Parmensis 78(3): 204-209
Mustacchi, G.; Milani, S.; Pluchinotta, A.; De Matteis, A.; Rubagotti, A.; Perrota, A. 1994: Tamoxifen or surgery plus tamoxifen as primary treatment for elderly patients with operable breast cancer: the G.R.E.T.A. Trial. Group for Research on Endocrine Therapy in the Elderly Anticancer Research 14(5b): 2197-2200
Epifani, S.; Lattarulo, S.; Maiorino, R.; Fabiano, G. 2000: Monitoring of postmenopausal women treated with tamoxifen for breast carcinoma Il Giornale di Chirurgia 21(6-7): 310-312
Heirler, F.; de la Motte, S.; Popp, W. 1995: Influence of metronidazole and tamoxifen in a case of otherwise untreated ulcerous breast carcinoma European Journal of Gynaecological Oncology 16(6): 448-452
Semiglazov, V.F.; Maximov, S.Y.; Bulgatova, Y., A.; Meshkova, I.Y.; Chepik, O.F.; Berstein, L.M. 2003: Risk of hyperplasia and endometrial carcinoma in breast cancer patients receiving adjuvant tamoxifen Voprosy Onkologii (Stsburg). 49(2): 198-204
Kelessis, N.G.; Vassilopoulos, P.P.; Galanopoulou, A.V.; Nessiotis, A.G.; Stravolemos, C.M. 2000: Administration of tamoxifen in the perioperative period to patients with breast carcinoma prolongs axillary fluid drainage Anticancer Research 20(2b): 1245-1248
Barakat, R.R. 1995: The effect of tamoxifen on the endometrium Oncology 9(2): 129-134; Discussion: 139-140, 142
Dallenbach-Hellweg, G.; Hahn, U.; Schmidt, D. 1996: Morphologic endometrium changes with tamoxifen Zentralblatt für Gynakologie 118(6): 365-369
Bai, P.; Sun, J.; Zhang, K. 2001: The effect of tamoxifen of endometrium Zhonghua Fu Chan Ke Za Zhi 36(4): 226-228
Cocconi, G.; Boni, C.; Naldi, N.; Nizzoli, R.; Bozzetti, C. 1989: Exacerbation of metastatic disease shortly after administration of tamoxifen in ER negative advanced breast carcinoma. A case report Tumori 75(6): 566-569
Brachetti, A.K.; Limburg, H. 1977: Ancillary chemotherapy in the primary treatment of carcinoma of the breast. on the growth pattern of carcinoma of the breast and the establishment of a new concept in treatment Geburtshilfe und Frauenheilkunde 37(2): 109-114